![](https://www.diabetesnews.com/wp-content/uploads/2014/03/NovoPen-Echo-Diagnostrum-e1379082082150-26723_320x260-150x150.jpg)
After a decade-long run, Novo Nordisk’s FlexPen is being retired. Yes, one of the most popular insulin pens for people with diabetes is on the way out after more than 1 billion have been sold through the years. And here comes Novo’s new next-gen FlexTouch.